HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma SA to create leading international Group in the CDMO sector, backed by 65 Equity Partners By 31 March 2025
Temasek-backed 65 Equity Partners sees global firms as possible source for IPO pipeline By 24 March 2025
65 Equity Partners’ two Singapore funds focus on driving growth in companies regardless of former listing status By 17 March 2025
